Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma

作者: Haofei Wang , Wujun Wang , Xuelian Wang , Kaican Cai , Hua Wu

DOI: 10.1007/S12032-012-0231-Y

关键词:

摘要: N-Myc downstream-regulated gene 2 (NDRG2) has been demonstrated to influence the metastatic potential of hepatocellular carcinoma and breast cancer cells by regulating CD24 expression. The aim this study was investigate roles NDRG2 in clinical pathology lung adenocarcinoma explore whether expression these two markers can be used as independent factors for prediction prognosis patients with tumor. paraffin-embedded specimens gathered from 166 detected immunohistochemical method. correlation proteins clinicopathological parameters statistically analyzed. were highly expressed 59/166 (35.5 %) 110/166 (66.3 patients, respectively. High frequently found tissues early pTNM stage (p = 0.01) without pathological metastasis 0.02), whereas high significantly associated advanced 0.04) 0.01). Univariate analysis indicated that correlated favorable 0.001), opposed 0.001). survival rate NDRG2-low/CD24-high lowest < Multivariate statistical showed conjoined expressions NDRG2-high/CD24-low prognostic indicators 0.03 p 0.02, respectively). Our results suggest decreased or increased is an important feature adenocarcinoma. A combined detection NDRG2/CD24 co-expression may benefit us

参考文章(28)
Silke Aigner, Zev M. Sthoeger, Mina Fogel, Erich Weber, Jürg Zarn, Michael Ruppert, Yvonka Zeller, Dietmar Vestweber, Rolf Stahel, Marei Sammar, Peter Altevogt, CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells Blood. ,vol. 89, pp. 3385- 3395 ,(1997) , 10.1182/BLOOD.V89.9.3385
Bo Liu, Yangde Zhang, Mingmei Liao, Zhansheng Deng, Liansheng Gong, Jiarui Jiang, Ling Lynn, Kai Wu, Xiongying Miao, Clinicopathologic and Prognostic Significance of CD24 in Gallbladder Carcinoma Pathology & Oncology Research. ,vol. 17, pp. 45- 50 ,(2011) , 10.1007/S12253-010-9278-2
G Kristiansen, K Schlüns, Y Yongwei, C Denkert, M Dietel, I Petersen, CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients British Journal of Cancer. ,vol. 88, pp. 231- 236 ,(2003) , 10.1038/SJ.BJC.6600702
Junye Liu, Jing Zhang, Xiaowu Wang, Yan Li, Yongbin Chen, Kangchu Li, Jian Zhang, Libo Yao, Guozhen Guo, HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells Experimental Cell Research. ,vol. 316, pp. 1985- 1993 ,(2010) , 10.1016/J.YEXCR.2010.02.028
Hyun-Soo Kim, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim, Expression of the mammalian target of rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma. Pathobiology. ,vol. 79, pp. 84- 93 ,(2012) , 10.1159/000334340
Sema Bircan, Nilgun Kapucuoglu, Sirin Baspinar, Gulsun Inan, Ozden Candir, CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathology Research and Practice. ,vol. 202, pp. 569- 576 ,(2006) , 10.1016/J.PRP.2006.05.004
Li Feng, Yun Xie, Hao Zhang, Yunlin Wu, Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochemical and Biophysical Research Communications. ,vol. 406, pp. 534- 538 ,(2011) , 10.1016/J.BBRC.2011.02.081
Yong Shi, Hong-Li Gong, Liang Zhou, Jie Tian, Yang Wang, CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. Operations Research Letters. ,vol. 74, pp. 78- 85 ,(2012) , 10.1159/000335584
Xiao-Lan Hu, Xin-Ping Liu, Yan-Chun Deng, Shu-Xin Lin, Lin Wu, Jian Zhang, Li-Feng Wang, Xiao-Bin Wang, Xia Li, Lan Shen, Yuan-Qiang Zhang, Li-Bo Yao, Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues Cell and Tissue Research. ,vol. 325, pp. 67- 76 ,(2006) , 10.1007/S00441-005-0137-5